Authors


Lorraine Provencher, MD

Latest:

Harnessing the Power of VR for Visual Field Testing: Results of The NOVA Trial

Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.


John Buch, OD, MS

Latest:

HEV filter contact lens technology helps reduce light scattering

John Buch, OD, MS, with JJV, shares an update on the company's HEV filter contact lens.


Andrew Rixon, OD, FAAO

Latest:

OCT in glaucoma management: Green isn’t always clean

Avoid color-scheme bias and vet all data before making treatment decisions


Denise A. Valenti, OD, FAAO

Latest:

New technology will allow roadside simulation for research on cannabis use and driving

Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.


Courtney Allen, OD

Latest:

Autism spectrum disorder in children requires patience, flexibility

How to tailor an eye examination and what technology to consider.


David Liao, MD

Latest:

Controversies in Modern Eye Care 2023: Evolving therapeutics for nAMD and DME

David Liao, MD, shares highlights from his discussion on evolving treatment strategies for neovascular AMD and DME, during the 17th annual Controversies in Modern Eye Care meeting.


Nicholas Colatrella, OD, FAAO, Dipl AAO, ABO, ABCMO

Latest:

Ocular findings of COVID-19

COVID-19 affects every part of the eye, front to back.


Wanyi Pan

Latest:

Future advances in glaucoma therapy

Medical and surgical technological advances show promise for future glaucoma management.


Gema Corpus, MSc

Latest:

Focusing on extended-depth-of-focus contact lenses for myopia control

Clinical pilot study evaluates effect after 1 month of wear.


Dina Erickson, OD, FAAO

Latest:

Victoria Conference 2023: Identifying glaucoma suspects

Dina Erickson, OD, FAAO, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from her talk on glaucoma suspects.



Ranjila Shyangbo

Latest:

Review Duane’s retraction syndrome diagnosis and treatment

Understand the condition’s structural, innervational, neurological, and genetic abnormalities


Kerry Salsberg, OD

Latest:

Swept-source and multimodal OCT technologies offer clinical advantages

The expenditure of embracing new technologies is worthwhile.




Behrad Garmsiri

Latest:

Future advances in glaucoma therapy

Medical and surgical technological advances show promise for future glaucoma management.


Tracie Lynn Thibault, OD candidate

Latest:

What is your diagnosis? Young boy complains of recurrent red eye

Pediatric TINU syndrome is rare, but responds well to treatment.


Kenneth Sawyer, OD

Latest:

When choosing refractive procedures, long-term planning is key

Considering recovery time, potential adverse effects, and future eye care needs can increase patient satisfaction.


Euin Cheong, OD

Latest:

Keeping patient care personalized

An introduction to cerebral visual impairment.


Alexis G. Malkin, OD, FAAO

Latest:

AAOpt 2022: Comanagement helps elevate the full holistic standard of care for the patient

Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.


Katheryn Cregan

Latest:

Diagnosing and treating optic nerve head drusen

Technologies that improve treatment of ONHD and similar pathologies.


Todd Peabody, OD, MBA, FAAO

Latest:

The optometrist’s role in diagnosing and treating hypertension

ODs have the rare opportunity to engage as well as educate patients on hypertension.


Julie Lafreniere, OD, FAAO

Latest:

Turning inexperience into expertise in fitting scleral lenses

Building confidence and knowledge can reduce office visits and increase results.


Harmin Chima, OD

Latest:

AOA 2023: Investigating 3-layer amniotic membrane graft as an emerging treatment for ocular surface disease

Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.



John Samples, MD

Latest:

Controversies in Modern Eye Care 2023: MIGS advancements

John Samples, MD, shares highlights from his the glaucoma panel discussion during the 2023 Controversies in Modern Eye Care meeting.


Khan Lau, OD, MBA, FAAO

Latest:

Treatments for presbyopia coming soon

These options increase the depth of field to address the symptoms of presbyopia


Shane Swatts, OD

Latest:

AOA 2023: Everything you need to know on intense pulse light

Shane Swatts, OD, reviewed the key points of his course on intense pulse light therapy.



Paul M. Karpecki, OD, FAAO

Latest:

Guideline redefines amniotic membrane’s role in ocular surface disease

Earlier and proactive use is suggested for a variety of corneal diseases

© 2024 MJH Life Sciences

All rights reserved.